Archive for August 28, 2015

KPC and NDM-1 Genes in Related Enterobacteriaceae Strains and Plasmids from Pakistan and the United States

Emerging Infectious Diseases Jun 2015 V.21 N.6

Dispatch

Mitchell W. Pesesky1, Tahir Hussain1, Meghan Wallace, Bin Wang, Saadia Andleeb, Carey-Ann D. Burnham, and Gautam Dantas

Washington University School of Medicine in St. Louis, St. Louis, Missouri, USA (M.W. Pesesky, T. Hussain. M. Wallace, B. Wang, C.D. Burnham, G. Dantas); National University of Sciences and Technology, Islamabad, Pakistan (T. Hussain, S. Andleeb)

To characterize the genomic context of New Delhi metallo-β-lactamase-1 (NDM-1) and Klebsiella pneumoniae carbapenemase (KPC), we sequenced 78 Enterobacteriaceae isolates from Pakistan and the United States encoding KPC, NDM-1, or no carbapenemase.

High similarities of the results indicate rapid spread of carbapenem resistance between strains, including globally disseminated pathogens.

PDF

http://wwwnc.cdc.gov/eid/article/21/6/pdfs/14-1504.pdf

Advertisements

August 28, 2015 at 8:21 am

Extensively Drug-Resistant New Delhi Metallo-β-Lactamase–Encoding Bacteria in the Environment, Dhaka, Bangladesh, 2012

Emerging Infectious Diseases Jun 2015 V.21 N.6

Dispatch

Mark A. Toleman, Joachim J. Bugert, and Syed A. Nizam

Cardiff University, Heath Park Campus, Cardiff, Wales, UK

Carriage of the New Delhi metallo-β-lactamase variant 1 (NDM-1) enables drug resistance to move between communities and hospitals.

In Bangladesh, we found the blaNDM-1 gene in 62% of environmental waters and in fermentative and nonfermentative gram-negative bacteria.

Escherichia coli sequence type (ST) 101 was most commonly found, reflecting a common global relationship between ST101 and NDM-1.

PDF

http://wwwnc.cdc.gov/eid/article/21/6/pdfs/14-1578.pdf

 

August 28, 2015 at 8:19 am

Bartonella spp. and Coxiella burnetii Associated with Community-Acquired, Culture-Negative Endocarditis, Brazil

Emerging Infectious Diseases Aug 2015 V.21 N.8

Dispatch

Rinaldo Focaccia Siciliano, Jussara Bianchi Castelli, Alfredo Jose Mansur, Fabiana Pereira dos Santos, Silvia Colombo, Elvira Mendes do Nascimento, Christopher D. Paddock, Roosecelis Araújo Brasil, Paulo Eduardo Neves Ferreira Velho, Marina Rovani Drummond, Max Grinberg, and Tania Mara Varejao Strabelli

University of São Paulo Medical School, São Paulo, Brazil (R.F. Siciliano, J.B. Castelli, A.J. Mansur, M. Grinberg, T.M.V. Strabelli); Adolfo Lutz Institute, São Paulo (F. Pereira dos Santos, S. Colombo, E.M. Nascimento, R.A. Brasil); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (C.D. Paddock); State University of Campinas Medical School, Campinas, Brazil (P.E.N.F. Velho, M.R. Drummond)

We evaluated culture-negative, community-acquired endocarditis by using indirect immunofluorescent assays and molecular analyses for Bartonella spp. and Coxiella burnetii and found a prevalence of 19.6% and 7.8%, respectively.

Our findings reinforce the need to study these organisms in patients with culture-negative, community-acquired endocarditis, especially B. henselae in cat owners.

PDF

http://wwwnc.cdc.gov/eid/article/21/8/pdfs/14-0343.pdf

August 28, 2015 at 8:18 am

Macrolide-Resistant Mycoplasma pneumoniae, United State

Emerging Infectious Diseases Aug 2015 V.21 N.8

Xiaotian ZhengComments to Author , Stella Lee, Rangaraj Selvarangan, Xuan Qin, Yi-Wei Tang, Jeffrey Stiles, Tao Hong, Kathleen Todd, Amy E. Ratliff, Donna M. Crabb, Li Xiao, T. Prescott Atkinson, and Ken B. Waites

Ann & Robert H. Lurie Children’s Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA (X. Zheng, S. Lee, K. Todd); The Children’s Mercy Hospitals and Clinics, Kansas City, Missouri, USA (R. Selvarangan); Seattle Children’s Hospital, Seattle, Washington, USA (X. Qin); Memorial Sloan-Kettering Cancer Center and Weill Medical College of Cornell University, New York, New York, USA (Y.W. Tang, J. Stiles); Hackensack University Medical Center, Hackensack, New Jersey, USA (T. Hong); University of Alabama at Birmingham, Birmingham, Alabama, USA (A.E. Ratliff, D.M. Crabb, L. Xiao, T.P. Atkinson, K.B. Waites)

Macrolide-resistant Mycoplasma pneumoniae (MRMP) is highly prevalent in Asia and is now being reported from Europe.

Few data on MRMP are available in the United States.

Using genotypic and phenotypic methods, we detected high-level MRMP in 13.2% of 91 M. pneumoniae­–positive specimens from 6 US locations.

PDF

http://wwwnc.cdc.gov/eid/article/21/8/pdfs/15-0273.pdf

August 28, 2015 at 8:16 am

Emerging Infections Program as Surveillance for Antimicrobial Drug Resistance

Emerging Infectious Diseases Sept 2015 V.21 N.9

Scott K. Fridkin, Angela A. Cleveland, Isaac See, and Ruth Lynfield

Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S.K. Fridkin, A.A. Cleveland, I. See); Minnesota Department of Public Health, St. Paul, Minnesota, USA (R. Lynfield)

Across the United States, antimicrobial drug–resistant infections affect a diverse population, and effective interventions require concerted efforts across various public health and clinical programs.

Since its onset in 1994, the Centers for Disease Control and Prevention Emerging Infections Program has provided robust and timely data on antimicrobial drug–resistant infections that have been used to inform public health action across a spectrum of partners with regard to many highly visible antimicrobial drug–resistance threats.

These data span several activities within the Program, including respiratory bacterial infections, health care–associated infections, and some aspects of foodborne diseases.

These data have contributed to estimates of national burden, identified populations at risk, and determined microbiological causes of infection and their outcomes, all of which have been used to inform national policy and guidelines to prevent antimicrobial drug–resistant infections.

PDF

http://wwwnc.cdc.gov/eid/article/21/9/pdfs/15-0512.pdf

August 28, 2015 at 8:14 am

Improved Phenotype-Based Definition for Identifying Carbapenemase Producers among Carbapenem-Resistant Enterobacteriaceae

Emerging Infectious Diseases Sept 2015 V.21 N.9

Emerging Infections Program

Nora Chea, Sandra N. Bulens, Thiphasone Kongphet-Tran, Ruth Lynfield, Kristin M. Shaw, Paula Snippes Vagnone, Marion A. Kainer, Daniel B. Muleta, Lucy Wilson, Elisabeth Vaeth, Ghinwa Dumyati, Cathleen Concannon, Erin C. Phipps, Karissa Culbreath, Sarah J. Janelle, Wendy M. Bamberg, Alice Y. Guh, Brandi Limbago, and Alexander J. Kallen

Centers for Disease Control and Prevention, Atlanta, Georgia, USA (N. Chea, S.N. Bulens, T. Kongphet-Tran, A.Y. Guh, B. Limbago, A.J. Kallen); Minnesota Department of Health, St. Paul, Minnesota, USA (R. Lynfield, K.M. Shaw, P. Snippes Vagnone); Tennessee Department of Health, Nashville, Tennessee, USA (M.A Kainer, D.B. Muleta); Maryland Emerging Infections Program, Baltimore, Maryland, USA (L. Wilson, E. Vaeth); New York–Rochester Emerging Infections Program, Rochester, New York, USA (G. Dumyati, C. Concannon); University of Rochester Medical Center, Rochester (G. Dumyati, C. Concannon); University of New Mexico, Albuquerque, New Mexico, USA (E.C. Phipps, K. Culbreath); Colorado Department of Public Health and Environment, Denver, Colorado, USA (S.J. Janelle, W.M. Bamberg)

Preventing transmission of carbapenemase-producing, carbapenem-resistant Enterobacteriaceae (CP-CRE) is a public health priority. A phenotype-based definition that reliably identifies CP-CRE while minimizing misclassification of non–CP-CRE could help prevention efforts.

To assess possible definitions, we evaluated enterobacterial isolates that had been tested and deemed nonsusceptible to >1 carbapenem at US Emerging Infections Program sites.

We determined the number of non-CP isolates that met (false positives) and CP isolates that did not meet (false negatives) the Centers for Disease Control and Prevention CRE definition in use during our study: 30% (94/312) of CRE had carbapenemase genes, and 21% (14/67) of Klebsiella pneumoniae carbapenemase–producing Klebsiella isolates had been misclassified as non-CP.

A new definition requiring resistance to 1 carbapenem rarely missed CP strains, but 55% of results were false positive; adding the modified Hodge test to the definition decreased false positives to 12%. This definition should be considered for use in carbapenemase-producing CRE surveillance and prevention.

PDF

http://wwwnc.cdc.gov/eid/article/21/9/pdfs/15-0198.pdf

August 28, 2015 at 8:13 am


Calendar

August 2015
M T W T F S S
« Jul   Sep »
 12
3456789
10111213141516
17181920212223
24252627282930
31  

Posts by Month

Posts by Category